Anti-Human TGF-beta 1 & LRRC32/GARP Bispecific Reference Antibody (Livmoniplimab, RUO)
Overview
| Catalog No. |
HF977036 |
| Brand |
abinScience |
| Species reactivity |
Human |
| Form |
Liquid |
| Storage buffer |
0.01M PBS pH 7.4 |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Isotype |
IgG4-kappa |
| Applications |
ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target |
Transforming growth factor beta-1 proprotein, LAP, TGF-beta-1, TGFB1, TGFB, GARP, Leucine-rich repeat-containing protein 32, Glycoprotein A repetitions predominant, D11S833E, Garpin, Transforming growth factor beta activator LRRC32, LRRC32 |
| Purification |
Protein A/G purified from cell culture supernatant. |
| Endotoxin level |
< 10 EU/mg |
| Expression system |
Mammalian cells |
| Accession |
P01137 & Q14392 |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | Bispecific, ABBV-151, ARGX-115, MHG-8, MHGARP-8, PR-17628442412004-88-5 |
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control |
Human IgG4 (S228P) Recombinant Isotype Control Antibody (13R4) (HP298207) |
Images
 Bioactivity |
SEC-HPLC detection for Research Grade Livmoniplimab. |